Liguori, Claudio

Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection

Liguori, C., Pierantozzi, M., Spanetta, M., Sarmati, L., Cesta, N., Iannetta, M., Ora, J., Mina, G. G., Puxeddu, E., Balbi, O., et al. (2020) · Brain, Behavior, and Immunity

Long-Term Effects of COVID-19COVID-19 Clinical Research Studies

Cited by 212

Epilepsy, amyloid-β, and D1 dopamine receptors: a possible pathogenetic link?

Costa, C., Parnetti, L., D'Amelio, M., Tozzi, A., Tantucci, M., Romigi, A., Siliquini, S., Cavallucci, V., Di Filippo, M., Mazzocchetti, P., et al. (2016) · Neurobiology of Aging

Epilepsy research and treatmentAlzheimer's disease research and treatments

Cited by 94

Sleep problems affect quality of life in Parkinson's disease along disease progression

Liguori, C., De Franco, V., Cerroni, R., Spanetta, M., Mercuri, N. B., Stefani, A., Pierantozzi, M., & Di Pucchio, A. (2021) · Sleep Medicine

Parkinson's Disease Mechanisms and TreatmentsSleep and related disorders

Cited by 61

Clinical practice guidelines for switching or deprescribing hypnotic medications for chronic insomnia: Results of European neuropsychopharmacology and sleep expert's consensus group

Palagini, L., Brugnoli, R., Dell’ Osso, B. M., Di Nicola, M., Maina, G., Martinotti, G., Maruani, J., Mauries, S., Serafini, G., Mencacci, C., et al. (2025) · Sleep Medicine

Sleep and related disordersPharmaceutical Practices and Patient Outcomes

Cited by 28

Cerebrospinal-fluid Alzheimer’s Disease Biomarkers and Blood-Brain Barrier Integrity in a Natural Population of Cognitive Intact Parkinson’s Disease Patients

Liguori, C., Olivola, E., Pierantozzi, M., Cerroni, R., Galati, S., Saviozzi, V., Mercuri, N. B., & Stefani, A. (2017) · CNS & Neurological Disorders - Drug Targets

Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research

Cited by 20